Rajiev

I, Raj SHARMA, nominated by Prof Woodcock (MTOC Chair), residing in UK, a (member/co-chair) of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Global Medical Affairs Lead at GSK. My responsibilities include Inhaler clinical development and communications
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following (if answer is yes, describe briefly)
   • Proprietary interests: I do not have a proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces). (add description of interest)
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. GSK has an interest in low carbon inhaler inhalers including development and potential business partnerships  
   • Employment, consultancy, directorship or other positions: I am a paid employee of GSK
   • Government advice and other policy development: (describe any interests relevant to the MCTOC activity, including any provision of advice to government, organisations or institutions involved in policy development)
   • Paid research activities, fellowships or grants: (describe any paid research activities, fellowships or grants relevant to the MCTOC activity)
   • Other interests:
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is GSK as required
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines (if have declined, add the following at the end of this statement “and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose”). 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Raj Sharma
Date: 05 MAY 2021